Clinical evaluation of chronic, intermittent, and short term hemoperfusions in patients with chronic renal failure using semipermeable microcapsules (artificial cells) formed from membrane-coated activated charcoal.
D000327:Adsorption; D000368:Aged; D001783:Blood Flow Velocity; D001792:Blood Platelets; D002214:Capsules; D002606:Charcoal; D003404:Creatinine / Q000097:blood*; D004617:Embolism / Q000517:prevention & control; D005260:Female; D005984:Glutethimide / Q000506:poisoning; D006146:Guanidines / Q000097:blood*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D007688:Kidneys, Artificial; D008567:Membranes, Artificial; D010424:Pentobarbital / Q000506:poisoning; D010477:Perfusion; D011041:Poisoning / Q000628:therapy; D012459:Salicylates / Q000506:poisoning; D014508:Urea / Q000097:blood*; D014527:Uric Acid / Q000097:blood*; D014882:Water-Electrolyte Balance
D002214:Capsules; D006146:Guanidines; D008567:Membranes, Artificial; D012459:Salicylates; D002606:Charcoal; D014527:Uric Acid; D014508:Urea; D003404:Creatinine; D005984:Glutethimide; D010424:Pentobarbital